Introduction
============

We propose this study in order to reach two end points: (a) vasospasm clinical incidence, confirmed by CT; and (b) the mortality of these patients in 28 days. The study shows a comparison of a group of patients that used Mg (Intervention Group 1) from those that did not (Control Group 2).

Methods
=======

After institutional approval and informed consent, a prospective, randomized, nonblind study was performed between February and November 2008. The main goal of the study was to achieve a Mg serum concentration from 2.5 to 3.5 mg/dl, using a solution of Mg 2% (SG 5% 400 ml + MgSO~4~10% 100 ml/24 hours), during the first 14 days of aneurysm rupture. Admission criteria: patients diagnosed with SAH and Δt \<96 hours. Exclusion criteria: patients with SAH and Δt \>96 hours.

Results
=======

In a previous study evaluation we analysed a total of 56 patients, with 26 in Group 1 and 30 in Group 2 (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Main results: Group 1 -- vasospasm frequency 26.9% (n = 7) and mortality 19.2% (n = 5) in 28 days; Group 2 -- vasospasm frequency 46.7% (n = 14) and mortality 33.3% (n = 10) in 28 days.

                      APACHE II   Average Mg level
  ------------------- ----------- ------------------
  Group I (n = 26)    8.2         2.32
  Group II (n = 30)   15.6        1.9

                         Group I (n = 26)   Group II (n = 30)                                        
  ---------------------- ------------------ ------------------- ----- ----------- -------------- --- -----
  Vasospasm              26.9 (7)           11.6 to 47.8        0.4   46.7 (14)   28.3 to 65.7   1   0.1
  Mortality in 28 days   19.2 (5)           6.6 to 39.4         0.5   33.3 (10)   17.3 to 52.8   1   0.2

CI, confidence interval; Freq., frequency; OR, odds ratio.

Conclusion
==========

According to the outcome, we can conclude that Group 1 obtained a greater protection for vasospasm incidence and a decrease of mortality in comparison with Group 2. The *P*value was not significant due to a still small number of patients.
